Investigation of regulation of CD95 ligand expression

Norian LA, Latinis KM, Eliason SL, Lyson K, Yang C, Ratliff T, Koretzky GA. The regulation of CD95 (Fas) ligand expression in primary T cells: induction of promoter activation in CD95LP-Luc transgenic mice. J Immunol. 2000 May 1;164(9):4471-80. PubMed PMID: 10779747.

Norian LA, Koretzky GA. Intracellular adapter molecules. Semin Immunol. 2000 Feb;12(1):43-54. Review. PubMed PMID: 10723797.

Cowdery JS, Boerth NJ, Norian LA, Myung PS, Koretzky GA. Differential regulation of the IL-12 p40 promoter and of p40 secretion by CpG DNA and lipopolysaccharide. J Immunol. 1999 Jun 1;162(11):6770-5. PubMed PMID: 10352297.

Norian LA, Latinis KM, Koretzky GA. A newly identified response element in the CD95 ligand promoter contributes to optimal inducibility in activated T lymphocytes. J Immunol. 1998 Aug 1;161(3):1078-82. PubMed PMID: 9686564.

Latinis KM, Norian LA, Eliason SL, Koretzky GA. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J Biol Chem. 1997 Dec 12;272(50):31427-34. PubMed PMID: 9395475.

Latinis KM, Carr LL, Peterson EJ, Norian LA, Eliason SL, Koretzky GA. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J Immunol. 1997 May 15;158(10):4602-11. PubMed PMID: 9144472.